✓
Open
10 Jan 2025
✓
Close
14 Jan 2025
3
Allotment
—
✓
Listing
Fri, Jan 17, 2025
Price Band
₹77 to ₹81
Issue Size
41,72,800 shares (agg. up to ₹34 Cr)
Lot Size
1,600 Shares
Listing Date
Fri, Jan 17, 2025
Latest GMP
₹40
Est. Gain
49.38%
✦ AI Insight
GMP Trend
17-01-2025₹40Est. ₹121+49.38%
16-01-2025₹40Est. ₹121+49.38%
15-01-2025₹50Est. ₹131+61.73%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 239.46x |
Restated Financials (₹ Cr.)
| Period Ended | 15 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 31.17 | 21.75 | 14.71 | 12.39 |
| Total Income | 109.55 | 128.11 | 82.98 | 52.31 |
| Profit After Tax | 5.90 | 6.31 | 2.51 | 1.39 |
| NET Worth | 17.28 | 9.43 | 3.27 | 0.77 |
| Reserves and Surplus | 5.71 | 6.63 | 2.57 | 0.07 |
| Total Borrowing | 4.03 | 1.78 | 3.75 | 8.15 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Onyx Biotec Ltd. | SME | ₹29.34 Cr | ₹61 | 26.81 | ₹56.75 | -6.97% | ₹39.55 (+4.91%) |
| Medicamen Organics Ltd. | SME | ₹10.54 Cr | ₹34 | 30.53 | ₹144.70 | +325.59% | ₹23.00 (-1.50%) |
| Quest Laboratories Ltd. | SME | ₹43.16 Cr | ₹97 | 23.03 | ₹147.35 | +51.91% | ₹96.95 (+8.08%) |
| Zenith Drugs Ltd. | SME | ₹40.68 Cr | ₹79 | 18.4 | ₹105.15 | +33.10% | ₹50.10 (-4.48%) |
| Senores Pharmaceuticals Ltd. | Mainboard | ₹582.11 Cr | ₹391 | 39.77 | ₹557.80 | +42.66% | ₹1,452.90 (-1.74%) |
| Sai Life Sciences Ltd. | Mainboard | ₹3,042.62 Cr | ₹549 | 126.42 | ₹764.65 | +39.28% | ₹1,294.90 (+2.45%) |
| Akums Drugs & Pharmaceuticals Ltd. | Mainboard | ₹1,856.74 Cr | ₹679 | null | ₹796.25 | +17.27% | ₹682.95 (-1.22%) |
| Emcure Pharmaceuticals Ltd. | Mainboard | ₹1,952.03 Cr | ₹1008 | 34.55 | ₹1,359.15 | +34.84% | ₹1,802.70 (+0.61%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To meet out the expenses of Unidentified Acquisition (In India or Abroad) | 5.00 |
| 2 | To meet out the expenses Marketing and Advertisement | 11.00 |
| 3 | To meet out the Capital Expenditure | 8.00 |
| 4 | To meet out the expenditure on Investment in Technology | 5.00 |
| 5 | To meet out the General corporate purposes | 1.25 |
| 6 | Issue Expenses | 3.55 |
| Total | 33.80 |
About Sat Kartar Shopping IPO
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company focused on delivering natural wellness solutions for therapeutic and lifestyle products, promoting a healthier lifestyle. The company offers holistic, natural remedies and lifestyle products based on traditional Ayurveda practices, serving individual consumers directly. It sells products through its own website, third-party e-commerce platforms, television marketing, and Google and Meta applications. Their Products: Specific Problem Led Niche Therapeutic Areas: The company targets specialized fields within the medical and healthcare domain that focus on addressing specific health issues or challenges such as addiction, personal care, wellness, and others. Products are Addiction Killer,Liv Muztang etc. Lifestyle Led Curative Areas:The company also targets specialized fields within healthcare and medicine that focus on addressing health issues related to individuals' lifestyles, such as diabetes, joint pain relief, piles, and other health concerns. The company is diversifying its product portfolio to include products related to various health issues such as slimming, hair care, gut health, PCOD (
Contact Details
Sat Kartar Shopping Ltd. Address603, 6th FloorMercantile HouseKG MargNew Delhi, New Delhi, 110001+91-9319888634info@satkartar.inVisit Website